<?xml version="1.0"?>
<rss version="2.0">
   <channel>
      <title>Benjamin Barrone - Series A Financing  by Benjamin Barrone</title>
      <link>https://padlet.com/BenjaminBarrone/55lxg31dttau</link>
      <description>Vital Proteins - start-to-finish venture capital financing</description>
      <language>en-us</language>
      <pubDate>2018-01-29 19:12:37 UTC</pubDate>
      <lastBuildDate>2018-01-29 19:38:25 UTC</lastBuildDate>
      <webMaster>hello@padlet.com</webMaster>
      <image>
         <url></url>
      </image>
      <item>
         <title>Series A Financing</title>
         <author>BenjaminBarrone</author>
         <link>https://padlet.com/BenjaminBarrone/55lxg31dttau/wish/225812153</link>
         <description><![CDATA[<div>Benjamin Barrone is a Finance and Accounting Professional located in Chicago, IL.&nbsp; Mr. Barrone recently helped Vital Proteins, a Chicago-based startup, secure a Series A financing round.&nbsp; In his capacity as Director of Finance Benjamin (Ben) Barrone led the efforts from Vital Proteins from start-to-finish in the venture capital funding process including:</div><ul><li>Strategic Partner Selection – engaged in company pitch, bid solicitation thru term sheets, and final selection based on qualitative and quantitative factors</li><li>Term Sheet Negotiation – including favorable valuation, waterfall distribution, board control, investor blocking rights, and incentive equity plan</li><li>Due Diligence – primary contact for anything finance-related including Quality of Earnings review by independent CPA firm and complete dataroom ownership</li><li>Disclosure Schedule – led coordination, compilation, drafting, editing, for all company disclosures with respect to representation and warranties in final purchase agreement including dataroom maintenance</li><li>Legal Review – including fine points of final agreements such as definition of “knowledge”, materiality qualifiers and threshold(s), distribution rights, and budget approval/control</li><li>Closing – tirelessly pushed deal to finish line, coordinating resources of CEO, attorneys (both sides), Senior Leadership Team, VC Investors, accountants, bankers, and consultants.</li></ul><div>This was the first external financing for Vital Proteins, having bypassed earlier needs through cash flow generated from operations and internal funding.&nbsp; A Series A financing round can be summarized as follows:<br><br><strong>Series A: Scaling the product and getting to a business model. (AKA getting to true product/market fit)</strong><br>&nbsp;</div><ul><li><strong>Purpose</strong>: With a series A you typically have figured out your product/userbase, and need capital to:</li><li><strong>Figure out or scale distribution.</strong> Your users may love your product, but you have not yet optimized all the ways to build a userbase.</li><li><strong>Scale geographically or across verticals</strong>. You have a product that works in one market (e.g. it works in the Bay Area), and you want to adapt it to other markets (lets launch it across the US or globally).</li><li><strong>Figure out a business model</strong>. If you are a consumer internet company, you may be getting lots of users, but may not have a clear business model that is working at this point (see e.g. Instagram).</li><li><strong>Amounts</strong>: Used to be $2m-$15million with a median of $3-$7 million.&nbsp; Series A amounts have <a href="http://blog.eladgil.com/2011/02/are-we-in-inflationary-part-of-internet.html">gone up dramatically</a> recently to more of a $7-15million raise being typical.</li><li><strong>Recent examples</strong>: <a href="http://techcrunch.com/2011/02/14/huge-vote-of-confidence-uber-raises-11-million-from-benchmark-capital/">Uber</a>(cab) raising from Benchmark, <a href="http://venturebeat.com/2011/02/02/instagram-benchmark-funding-2/">Instagram's</a> raise from Benchmark</li><li><strong>Who invests</strong>: Your traditional venture funds (Sequoia, A16Z, Benchmark, Accel, Greylock, Battery, CRV, Matrix etc etc.). lead these rounds, leading to a pretty different dynamic relative to a seed round (more on this in another post).&nbsp; Angels may co-invest with VCs in the A, but they have no power to set the pricing or impact any aspect of the round.</li></ul>]]></description>
         <enclosure url="" />
         <pubDate>2018-01-29 19:17:16 UTC</pubDate>
         <guid>https://padlet.com/BenjaminBarrone/55lxg31dttau/wish/225812153</guid>
      </item>
   </channel>
</rss>
